Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LGND | AMGN | GILD | BIIB | CELG |
| Company | Ligand Pharm | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 73.50 | 301.75 | 65.43 | 221.52 | 108.01 |
| High | 75.62 | 302.91 | 66.14 | 221.98 | 108.59 |
| Low | 73.16 | 298.51 | 65.16 | 216.08 | 107.27 |
| Last | 74.31 | 300.93 | 65.91 | 218.43 | 108.24 |
| Change | +1.48 | +1.45 | +0.37 | -2.99 | +0.11 |
| % Change | +2.03% | +0.48% | +0.56% | -1.35% | +0.10% |
| Volume | 85,552 | 1,601,825 | 3,321,808 | 704,152 | 191,230,496 |
| 20-Day Average Volume | 144,998 | 2,777,398 | 7,393,007 | 1,352,290 | 16,188,930 |
| Previous Close | 72.83 | 299.48 | 65.54 | 221.42 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 74.09 | 275.24 | 66.49 | 204.53 | 108.17 |
| 20-Day Raw Stochastic | 41.54% | 62.63% | 29.19% | 88.53% | 63.25% |
| 20-Day Relative Strength | 49.79% | 62.68% | 36.87% | 56.48% | 64.69% |
| Weighted Alpha | +2.84 | +27.62 | -19.37 | -27.32 | +46.30 |
| Today's Opinion | 24% Buy | 40% Buy | 100% Sell | 56% Sell | 100% Buy |
| Previous Opinion | 24% Buy | 24% Buy | 100% Sell | 56% Sell | 100% Buy |
| Last Month's Opinion | 88% Buy | 24% Sell | 100% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.22% since 04/30/24 | +9.32% since 04/30/24 | +1.10% since 04/30/24 | +1.77% since 04/30/24 | -1.97% since 11/13/19 |
| Low | 69.51 on 05/01/24 | 273.38 on 05/01/24 | 64.33 on 05/03/24 | 213.11 on 05/03/24 | 107.27 on 11/20/19 |
| High | 75.61 on 05/07/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 222.40 on 05/06/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -5.67% since 04/05/24 | +10.93% since 04/05/24 | -5.27% since 04/05/24 | +7.24% since 04/05/24 | +5.14% since 10/18/19 |
| Low | 67.72 on 04/22/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 81.73 on 04/12/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 222.40 on 05/06/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -1.30% since 02/07/24 | +1.21% since 02/07/24 | -11.43% since 02/07/24 | -9.11% since 02/07/24 | +13.63% since 08/20/19 |
| Low | 67.72 on 04/22/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 94.57 on 02/27/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 244.95 on 02/12/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +38.34% since 11/07/23 | +10.46% since 11/07/23 | -18.23% since 11/07/23 | -10.99% since 11/07/23 | +14.14% since 05/20/19 |
| Low | 51.21 on 11/09/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 94.57 on 02/27/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,289,455 | 160,633,888 | 81,602,352 | 32,238,088 | 77,035,920 |
| Shares Outstanding, K | 17,705 | 536,376 | 1,245,077 | 145,597 | 711,714 |
| Annual Sales | 131,310,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | 52,150,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 28,100,000 | 7,447,000,000 | 6,686,000,000 | 2,290,500,000 | 4,520,000,000 |
| Last Quarter Net Income | 18,190,000 | -113,000,000 | -4,170,000,000 | 393,400,000 | 1,691,000,000 |
| 60-Month Beta | 1.01 | 0.60 | 0.22 | -0.01 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.05 on 02/27/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 3.67 on 04/24/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | 2.500 on 04/03/07 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 16.21 | 16.71 | 16.07 | 14.50 | 10.99 |